Dermatology
News
FDA Clears AI-Powered Device for Noninvasive Skin Cancer Testing
The FDA said in a statement that the device “should not be used as the sole diagnostic criterion nor to confirm a diagnosis of skin cancer.”
News
Efficacy of Topical Clascoterone for Acne Increased Over Time, Analysis Shows
“Clinicians may consider counseling patients that treatment persistence is required to maximize the efficacy of clascoterone treatment,” the...
News
Analysis Finds Risk of Alopecia Areata After COVID-19 Infection
The cohort consisted of 259,369 patients with COVID-19 and 259,369 uninfected controls.
News
Study Identifies Cardiovascular Comorbidities Associated With Dermatomyositis
"Our findings are important both for prognosis and clinical care," the authors concluded.
News
Myo-inositol is one of the components of an integrative approach to acne
Myo-inositol has been well-studied in patients with polycystic ovary syndrome (PCOS), demonstrating an ability to improve the metabolic profile...
News
US Dermatologic Drug Approvals Rose Between 2012 and 2022
The study authors identified 52 new drug applications and 26 supplemental new indications approved by the FDA for dermatologic indications between...
News
Experimental Topical Drug Shows Promise for Atopic Dermatitis and Plaque Psoriasis
PDE4 inhibitors are a promising therapeutic target for inflammatory diseases because “they can increase cyclic adenosine monophosphate levels and...
Conference Coverage
Expert Frames Factors to Consider Among Atopic Dermatitis Treatment Options
“There isn’t going to be a one-size-fits-all approach.”
News
‘Milestone’ Study Zeros in on 5-Year Safety Data From Upadacitinib Trials
“This is the longest safety study ever published for any systemic drug for AD,” Christopher G. Bunick, MD, said.
News
Paradoxical Eczema Risk Low With Biologic Psoriasis Treatments
The study included data for all currently available biologics, “originating from more than 160 dermatology centers in the UK and Ireland,” the...